Insider Transactions in Q1 2021 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2021
|
Jeffrey Trigilio Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,250
+50.0%
|
$47,250
$21.0 P/Share
|
|
Jan 12
2021
|
Owen Hughes President and CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.49%
|
$52,500
$21.0 P/Share
|
|
Jan 12
2021
|
Morana Jovan Embiricos > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+31.64%
|
$4,200,000
$21.0 P/Share
|
|
Jan 12
2021
|
Morana Jovan Embiricos > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
5,826,832
+43.61%
|
-
|
|
Jan 12
2021
|
Ansbert Gadicke Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+3.65%
|
$6,300,000
$21.0 P/Share
|
|
Jan 12
2021
|
Ansbert Gadicke Director |
BUY
Conversion of derivative security
|
Indirect |
7,613,887
+31.4%
|
-
|
|
Jan 12
2021
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+3.65%
|
$6,300,000
$21.0 P/Share
|
|
Jan 12
2021
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
7,613,887
+31.4%
|
-
|
|
Jan 07
2021
|
Ansbert Gadicke Director |
BUY
Other acquisition or disposition
|
Direct |
281,268
+50.0%
|
-
|